RAYTECH HOLDING LTD (RAY) Stock Fundamental Analysis

NASDAQ:RAY • VGG7385S1193

4.27 USD
+0.01 (+0.23%)
Last: Mar 3, 2026, 04:30 PM
Fundamental Rating

6

We assign a fundamental rating of 6 out of 10 to RAY. RAY was compared to 23 industry peers in the Distributors industry. Both the health and profitability get an excellent rating, making RAY a very profitable company, without any liquidiy or solvency issues. RAY has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

7

1. Profitability

1.1 Basic Checks

  • RAY had positive earnings in the past year.
  • RAY had a positive operating cash flow in the past year.
  • Each year in the past 5 years RAY has been profitable.
  • Each year in the past 5 years RAY had a positive operating cash flow.
RAY Yearly Net Income VS EBIT VS OCF VS FCFRAY Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2021 2022 2023 2024 2025 5M 10M 15M

1.2 Ratios

  • With an excellent Return On Assets value of 8.89%, RAY belongs to the best of the industry, outperforming 82.61% of the companies in the same industry.
  • RAY has a Return On Equity of 11.07%. This is in the better half of the industry: RAY outperforms 78.26% of its industry peers.
  • RAY has a Return On Invested Capital of 8.21%. This is in the better half of the industry: RAY outperforms 73.91% of its industry peers.
  • RAY had an Average Return On Invested Capital over the past 3 years of 21.00%. This is significantly above the industry average of 10.85%.
  • The last Return On Invested Capital (8.21%) for RAY is well below the 3 year average (21.00%), which needs to be investigated, but indicates that RAY had better years and this may not be a problem.
Industry RankSector Rank
ROA 8.89%
ROE 11.07%
ROIC 8.21%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
RAY Yearly ROA, ROE, ROICRAY Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2021 2022 2023 2024 2025 20 40 60 80

1.3 Margins

  • Looking at the Profit Margin, with a value of 11.19%, RAY belongs to the top of the industry, outperforming 91.30% of the companies in the same industry.
  • RAY's Profit Margin has declined in the last couple of years.
  • The Operating Margin of RAY (10.61%) is better than 82.61% of its industry peers.
  • In the last couple of years the Operating Margin of RAY has declined.
  • RAY's Gross Margin of 23.80% is fine compared to the rest of the industry. RAY outperforms 73.91% of its industry peers.
  • In the last couple of years the Gross Margin of RAY has declined.
Industry RankSector Rank
OM 10.61%
PM (TTM) 11.19%
GM 23.8%
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
RAY Yearly Profit, Operating, Gross MarginsRAY Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2021 2022 2023 2024 2025 5 10 15 20 25

9

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so RAY is creating value.
  • Compared to 1 year ago, RAY has more shares outstanding
  • RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
RAY Yearly Shares OutstandingRAY Yearly Shares OutstandingYearly Shares Outstanding 2021 2022 2023 2024 2025 200K 400K 600K 800K 1M
RAY Yearly Total Debt VS Total AssetsRAY Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2021 2022 2023 2024 2025 20M 40M 60M 80M

2.2 Solvency

  • RAY has an Altman-Z score of 4.34. This indicates that RAY is financially healthy and has little risk of bankruptcy at the moment.
  • RAY has a Altman-Z score of 4.34. This is in the better half of the industry: RAY outperforms 60.87% of its industry peers.
  • RAY has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Altman-Z 4.34
ROIC/WACC0.86
WACC9.51%
RAY Yearly LT Debt VS Equity VS FCFRAY Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2021 2022 2023 2024 2025 20M 40M 60M

2.3 Liquidity

  • RAY has a Current Ratio of 5.06. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
  • RAY has a Current ratio of 5.06. This is amongst the best in the industry. RAY outperforms 82.61% of its industry peers.
  • RAY has a Quick Ratio of 4.86. This indicates that RAY is financially healthy and has no problem in meeting its short term obligations.
  • Looking at the Quick ratio, with a value of 4.86, RAY belongs to the top of the industry, outperforming 86.96% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.06
Quick Ratio 4.86
RAY Yearly Current Assets VS Current LiabilitesRAY Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2021 2022 2023 2024 2025 20M 40M 60M 80M

3

3. Growth

3.1 Past

  • The earnings per share for RAY have decreased strongly by -28.82% in the last year.
  • Measured over the past years, RAY shows a decrease in Earnings Per Share. The EPS has been decreasing by -4.13% on average per year.
  • RAY shows a small growth in Revenue. In the last year, the Revenue has grown by 5.53%.
  • The Revenue has been growing by 20.41% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)-28.82%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-41.38%
Revenue 1Y (TTM)5.53%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%-13.11%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
RAY Yearly Revenue VS EstimatesRAY Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2021 2022 2023 2024 2025 20M 40M 60M

4

4. Valuation

4.1 Price/Earnings Ratio

  • RAY is valuated cheaply with a Price/Earnings ratio of 3.31.
  • Based on the Price/Earnings ratio, RAY is valued cheaply inside the industry as 100.00% of the companies are valued more expensively.
  • When comparing the Price/Earnings ratio of RAY to the average of the S&P500 Index (26.83), we can say RAY is valued rather cheaply.
Industry RankSector Rank
PE 3.31
Fwd PE N/A
RAY Price Earnings VS Forward Price EarningsRAY Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0

4.2 Price Multiples

  • Compared to the rest of the industry, the Price/Free Cash Flow ratio of RAY indicates a somewhat cheap valuation: RAY is cheaper than 65.22% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 17.65
EV/EBITDA -2.5
RAY Per share dataRAY EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 1 2 3 4 5

4.3 Compensation for Growth

  • RAY has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • RAY does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

RAYTECH HOLDING LTD

NASDAQ:RAY (3/3/2026, 4:30:05 PM)

4.27

+0.01 (+0.23%)

Chartmill FA Rating
GICS IndustryGroupConsumer Discretionary Distribution & Retail
GICS IndustryDistributors
Earnings (Last)01-15
Earnings (Next)N/A
Inst Owners1.18%
Inst Owner ChangeN/A
Ins Owners19.79%
Ins Owner ChangeN/A
Market Cap11.61M
Revenue(TTM)116.32M
Net Income(TTM)13.02M
AnalystsN/A
Price TargetN/A
Short Float %3.36%
Short Ratio1.05
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 3.31
Fwd PE N/A
P/S 0.78
P/FCF 17.65
P/OCF 17.65
P/B 0.77
P/tB 0.77
EV/EBITDA -2.5
EPS(TTM)1.29
EY30.21%
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)0.24
FCFY5.66%
OCF(TTM)0.24
OCFY5.66%
SpS5.47
BVpS5.53
TBVpS5.53
PEG (NY)N/A
PEG (5Y)N/A
Graham Number12.67
Profitability
Industry RankSector Rank
ROA 8.89%
ROE 11.07%
ROCE 10.49%
ROIC 8.21%
ROICexc N/A
ROICexgc N/A
OM 10.61%
PM (TTM) 11.19%
GM 23.8%
FCFM 4.42%
ROA(3y)14.95%
ROA(5y)27.53%
ROE(3y)24.16%
ROE(5y)43.37%
ROIC(3y)21%
ROIC(5y)38.94%
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)26.84%
ROCE(5y)49.77%
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y-25.8%
OM growth 5YN/A
PM growth 3Y-20.54%
PM growth 5YN/A
GM growth 3Y-5.54%
GM growth 5YN/A
F-Score5
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0
Debt/EBITDA 0
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage 250
Cash Conversion 41.7%
Profit Quality 39.53%
Current Ratio 5.06
Quick Ratio 4.86
Altman-Z 4.34
F-Score5
WACC9.51%
ROIC/WACC0.86
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)135.97%
Profit Quality(5y)122.72%
High Growth Momentum
Growth
EPS 1Y (TTM)-28.82%
EPS 3Y-4.13%
EPS 5YN/A
EPS Q2Q%-41.38%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)5.53%
Revenue growth 3Y20.41%
Revenue growth 5YN/A
Sales Q2Q%-13.11%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-19.22%
EBIT growth 3Y-10.65%
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-71.52%
FCF growth 3Y-8.86%
FCF growth 5YN/A
OCF growth 1Y-71.52%
OCF growth 3Y-8.91%
OCF growth 5YN/A

RAYTECH HOLDING LTD / RAY FAQ

Can you provide the ChartMill fundamental rating for RAYTECH HOLDING LTD?

ChartMill assigns a fundamental rating of 6 / 10 to RAY.


Can you provide the valuation status for RAYTECH HOLDING LTD?

ChartMill assigns a valuation rating of 4 / 10 to RAYTECH HOLDING LTD (RAY). This can be considered as Fairly Valued.


Can you provide the profitability details for RAYTECH HOLDING LTD?

RAYTECH HOLDING LTD (RAY) has a profitability rating of 7 / 10.


Can you provide the financial health for RAY stock?

The financial health rating of RAYTECH HOLDING LTD (RAY) is 9 / 10.